Overview

Improving Drop Instillation Comfort of a Cyclosporine A Solution

Status:
Recruiting
Trial end date:
2024-04-30
Target enrollment:
Participant gender:
Summary
Patients who suffer from dry eye disease are often prescribed eye drops containing cyclosporine A that help with reducing inflammation. The newest eye drop containing cyclosporine A is called Cequa (Sun Pharma, Canada). Unfortunately, nearly a quarter of (24.2%) of patients using Cequa have reported some form of discomfort (burning and stinging) when instilling the drops. This potentially discourages patients from continuing the eye drop, which prevents their dry eye disease from being managed effectively. This study is trying to determine if refrigerating the eye drops would allow the drops to feel more comfortable when they are instilled in the eye.
Phase:
N/A
Details
Lead Sponsor:
University of Waterloo
Collaborator:
Sun Pharmaceutical Industries Limited
Treatments:
Cyclosporine
Cyclosporins
Ophthalmic Solutions